Company registration number 13209470 (England and Wales)
NADEMI CLINICAL LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2026
NADEMI CLINICAL LTD
COMPANY INFORMATION
Director
Dr Mana Nademi
Company number
13209470
Registered office
36 Green Dragon Lane
Brentford
Middlesex
UK
TW8 0EN
Accountants
VPC Accountants Limited
Sanjita Bhavan
101 Brookdene Avenue
Watford
Greater London
WD19 4LG
NADEMI CLINICAL LTD
CONTENTS
Page
Director's report
1
Accountants' report
2
Profit and loss account
3
Balance sheet and notes to the financial statements
4
NADEMI CLINICAL LTD
DIRECTOR'S REPORT
FOR THE PERIOD ENDED 31 MARCH 2026
- 1 -

The director presents her annual report and financial statements for the period ended 31 March 2026.

Principal activities

The principal activity of the company continued to be that of dental practice activities.

Director

The director who held office during the period and up to the date of signature of the financial statements was as follows:

Dr Mana Nademi

This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies' exemption.

On behalf of the board
..............................................
Dr Mana Nademi
Director
21 September 2026
NADEMI CLINICAL LTD
ACCOUNTANTS' REPORT TO THE DIRECTOR ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF NADEMI CLINICAL LTD FOR THE PERIOD ENDED 31 MARCH 2026
- 2 -

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Nademi Clinical Ltd for the period ended 31 March 2026, which comprise the profit and loss account and the balance sheet, from the company’s accounting records and from information and explanations you have given us.

 

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at https://www.icaew.com/regulation.

This report is made solely to the board of directors of Nademi Clinical Ltd, as a body, in accordance with the terms of the engagement letter dated 29 March 2024. Our work has been undertaken solely to prepare for your approval the financial statements of Nademi Clinical Ltd and state those matters that we have agreed to state to the board of directors of Nademi Clinical Ltd, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Nademi Clinical Ltd and its board of directors as a body, for our work or for this report.

It is your duty to ensure that Nademi Clinical Ltd has kept adequate accounting records and to prepare statutory financial statements that comply with the requirements of the Companies Act 2006. You consider that Nademi Clinical Ltd is exempt from the statutory audit requirement for the period.

We have not been instructed to carry out an audit or a review of the financial statements of Nademi Clinical Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

VPC Accountants Limited
Chartered Accountants
21 September 2026
Sanjita Bhavan
101 Brookdene Avenue
Watford
Greater London
WD19 4LG
NADEMI CLINICAL LTD
PROFIT AND LOSS ACCOUNT
FOR THE PERIOD ENDED 31 MARCH 2026
- 3 -
Year
Year
ended
ended
31 March
31 March
2026
2025
£
£
Turnover
95,927
62,739
Cost of raw materials and consumables
(6,630)
(7,947)
Staff costs
(3,200)
(4,772)
Depreciation and other amounts written off assets
(5,000)
(5,000)
Other charges
(33,577)
(30,047)
Tax
(9,510)
(3,220)
Profit for the financial period
38,010
11,753
NADEMI CLINICAL LTD
BALANCE SHEET
AS AT
31 MARCH 2026
31 March 2026
- 4 -
2026
2025
£
£
£
£
Fixed assets
5,000
10,000
Current assets
12,084
6,042
Creditors: amounts falling due within one year
(11,485)
(10,104)
Net current assets/(liabilities)
599
(4,062)
Total assets less current liabilities
5,599
5,938
Net assets
5,599
5,938
Capital and reserves
5,599
5,938
Notes to the financial statements
1
Employees

The average number of persons, including directors, employed by the company during the period was as follows:

2026
2025
Number
Number
Employees
1
1

Nademi Clinical Ltd is a private company limited by shares incorporated in England and Wales. The registered office is 36 Green Dragon Lane, Brentford, Middlesex, UK, TW8 0EN.

For the period ended 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476.

These financial statements have been prepared in accordance with the micro-entity provisions and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

The financial statements were approved and signed by the director and authorised for issue on 21 September 2026
..............................................
Dr Mana Nademi
Director
Company registration number 13209470 (England and Wales)
2026-03-312025-04-01falsefalseCCH SoftwareCCH Accounts Production 2026.100Dr Mana Nademifalse132094702025-04-012026-03-3113209470bus:Director12025-04-012026-03-3113209470bus:RegisteredOffice2025-04-012026-03-31132094702026-03-31132094702024-04-012025-03-31132094702025-03-3113209470core:CurrentFinancialInstrumentscore:WithinOneYear2026-03-3113209470core:CurrentFinancialInstrumentscore:WithinOneYear2025-03-3113209470bus:PrivateLimitedCompanyLtd2025-04-012026-03-3113209470bus:Micro-entities2025-04-012026-03-3113209470bus:AuditExemptWithAccountantsReport2025-04-012026-03-3113209470bus:FullAccounts2025-04-012026-03-31xbrli:purexbrli:sharesiso4217:GBP